查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1544120

經導管主動脈瓣置換術的全球市場

Transcatheter Aortic Valve Replacement Procedures
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 197 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

到 2030 年，全球經導管主動脈瓣置換術市場預計將達到 183 億美元

經導管主動脈瓣置換術的全球市場預計 2023 年為 73 億美元，預計到 2030 年將達到 183 億美元，2023-2030 年分析期間複合年成長率為 14.0%。經股動脈手術是本報告分析的細分市場之一，預計複合年成長率為 14.8%，到分析期結束時將達到 170 億美元。在分析期間，鎖骨下手術部分的複合年成長率估計為 7.4%。

美國市場預計20億美元，中國預計複合年成長率13.0%

預計到 2023 年，美國經導管主動脈瓣置換術市場將達到 20 億美元。中國作為世界第二大經濟體，預計2030年市場規模將達27億美元，2023-2030年分析期間複合年成長率為13.0%。其他值得注意的區域市場包括日本和加拿大，在分析期間預計複合年成長率分別為 12.9% 和 11.8%。在歐洲，德國的複合年成長率預計約為 9.9%。

全球經導管主動脈瓣置換術市場 - 主要趨勢與促進因素總結

什麼是經導管主動脈瓣置換術以及為什麼它很重要？

經導管主動脈瓣置換術(TAVR) 是一種微創手術，用於治療嚴重主動脈瓣狹窄，即主動脈瓣變窄並限制心臟血流的情況。在 TAVR 手術中，通常會透過股動脈插入導管來更換瓣膜，因此不需要進行心臟直視手術。這些手術對於因年齡或合併症而面臨傳統主動脈瓣置換術(SAVR) 高風險的患者至關重要。 TAVR 提供了一種微創替代方案，恢復時間短，併發症低，使其成為改善主動脈瓣狹窄治療患者預後的重要選擇。

TAVR 手術如何改善病患的治療效果？

TAVR 治療透過為嚴重主動脈瓣狹窄提供更安全、侵入性較小的治療方法來改善患者的預後。 TAVR 是微創手術，與傳統的心臟直視手術相比，住院時間更短、恢復更快、疼痛更少。這種方法還可以最大限度地降低心臟直視手術中常見併發症的風險，例如感染疾病和出血。 TAVR 已被證明可以透過緩解主動脈瓣狹窄的症狀（例如呼吸急促、疲勞和胸痛）來顯著改善患者的生活品質。此外，TAVR 與較低的死亡率和改善的長期存活率相關，特別是對於不適合 SAVR 的高風險患者。

為什麼 TAVR 手術的採用越來越多？

由於幾個重要因素，TAVR 手術的採用正在增加。世界人口老化和主動脈瓣狹窄（尤其是老年人）盛行率的不斷增加，增加了對有效治療方案的需求。醫療技術和診斷影像技術的進步使 TAVR 手術更安全、更有效，使更多患者更容易接受。臨床試驗和研究表明 TAVR 相對於傳統手術方法的優勢也有助於其越來越受到醫療保健專業人員的認可。此外，下一代 TAVR 設備的開發以及擴大適應症以包括中度風險和低風險患者也支持了這些手術的採用。對改善患者預後和生活品質的關注進一步增加了對 TAVR 作為主動脈瓣狹窄首選治療選擇的需求。

推動 TAVR 手術市場成長的因素有哪些？

經導管主動脈瓣置換術市場的成長受到多種因素的推動。主動脈瓣狹窄的盛行率不斷增加，特別是在人口老化中，對有效的治療方案產生了巨大的需求。 TAVR 設備和手術的技術進步將提高這些手術的安全性和有效性，並促進其採用。臨床證據支持 TAVR 優於傳統手術方法，有助於其越來越受到醫療保健提供者和患者的接受。 TAVR 適應症的擴大，包括在中危險群和低危險群患者中的使用，正在進一步推動市場成長。對縮短恢復時間和改善患者治療效果的微創手術的重視也推動了對 TAVR 的需求。此外，為改善 TAVR 技術和治療效果而進行的持續研發工作，以及有利的報銷政策，也為市場擴張做出了重大貢獻。

受訪企業範例（47家知名企業）

  • Abbott Laboratories
  • Boston Scientific Corporation
  • Bracco SpA
  • Edwards Lifesciences Corporation
  • Jenavalve Technology, Inc.
  • Medtronic PLC
  • Meril Life Sciences Pvt., Ltd.

目錄

第1章調查方法

第 2 章執行摘要

  • 市場概況
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲國家
  • 亞太地區
  • 其他領域

第4章 比賽

簡介目錄
Product Code: MCP15285

Global Transcatheter Aortic Valve Replacement Procedures Market to Reach US$18.3 Billion by 2030

The global market for Transcatheter Aortic Valve Replacement Procedures estimated at US$7.3 Billion in the year 2023, is expected to reach US$18.3 Billion by 2030, growing at a CAGR of 14.0% over the analysis period 2023-2030. Transfemoral Procedure, one of the segments analyzed in the report, is expected to record a 14.8% CAGR and reach US$17.0 Billion by the end of the analysis period. Growth in the Subclavian Procedure segment is estimated at 7.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.0 Billion While China is Forecast to Grow at 13.0% CAGR

The Transcatheter Aortic Valve Replacement Procedures market in the U.S. is estimated at US$2.0 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$2.7 Billion by the year 2030 trailing a CAGR of 13.0% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 12.9% and 11.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 9.9% CAGR.

Global Transcatheter Aortic Valve Replacement Procedures Market - Key Trends & Drivers Summarized

What are Transcatheter Aortic Valve Replacement Procedures and Why are They Critical?

Transcatheter Aortic Valve Replacement (TAVR) Procedures are minimally invasive surgeries used to treat severe aortic stenosis, a condition where the aortic valve becomes narrowed, restricting blood flow from the heart. TAVR procedures involve the insertion of a replacement valve via a catheter, usually through the femoral artery, eliminating the need for open-heart surgery. These procedures are critical for patients who are at high risk for conventional surgical aortic valve replacement (SAVR) due to age or comorbid conditions. TAVR offers a less invasive alternative with shorter recovery times and reduced risk of complications, making it a vital option for improving patient outcomes in aortic stenosis treatment.

How Do TAVR Procedures Enhance Patient Outcomes?

TAVR Procedures enhance patient outcomes by providing a safer and less invasive treatment option for severe aortic stenosis. The minimally invasive nature of TAVR results in shorter hospital stays, faster recovery times, and reduced pain compared to traditional open-heart surgery. This approach also minimizes the risk of complications, such as infections and bleeding, which are more common in open-heart procedures. TAVR has shown to significantly improve the quality of life for patients by alleviating symptoms of aortic stenosis, such as shortness of breath, fatigue, and chest pain. Additionally, TAVR is associated with lower mortality rates and better long-term survival, particularly in high-risk patients who are not suitable candidates for SAVR.

Why is the Adoption of TAVR Procedures Increasing?

The adoption of TAVR Procedures is increasing due to several critical factors. The aging global population and the rising prevalence of aortic stenosis, particularly among the elderly, create a growing demand for effective treatment options. Advances in medical technology and imaging techniques have improved the safety and efficacy of TAVR procedures, making them more accessible to a broader patient population. Clinical trials and studies demonstrating the benefits of TAVR over traditional surgical approaches have also contributed to its growing acceptance among healthcare providers. Additionally, the development of next-generation TAVR devices and expanding indications for their use, including intermediate-risk and low-risk patients, are driving the adoption of these procedures. The focus on improving patient outcomes and quality of life further propels the demand for TAVR as a preferred treatment option for aortic stenosis.

What Factors are Driving the Growth of the TAVR Procedures Market?

The growth in the Transcatheter Aortic Valve Replacement Procedures market is driven by several factors. The increasing prevalence of aortic stenosis, particularly among the aging population, creates a significant demand for effective treatment options. Technological advancements in TAVR devices and procedural techniques enhance the safety and efficacy of these procedures, driving their adoption. Clinical evidence supporting the benefits of TAVR over traditional surgical approaches contributes to its growing acceptance among healthcare providers and patients. Expanding indications for TAVR, including its use in intermediate-risk and low-risk patients, further fuel market growth. The emphasis on minimally invasive procedures that offer faster recovery times and improved patient outcomes also drives the demand for TAVR. Additionally, ongoing research and development efforts to improve TAVR technology and outcomes, along with favorable reimbursement policies, significantly contribute to market expansion.

Select Competitors (Total 47 Featured) -

  • Abbott Laboratories
  • Boston Scientific Corporation
  • Bracco SpA
  • Edwards Lifesciences Corporation
  • Jenavalve Technology, Inc.
  • Medtronic PLC
  • Meril Life Sciences Pvt., Ltd.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Transcatheter Aortic Valve Replacement Procedures - Global Key Competitors Percentage Market Share in 2024 (E)
    • Global Economic Update
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Prevalence of Cardiovascular Diseases
    • Growing Aging Population and Associated Heart Conditions
    • Advancements in TAVR Device Technology
    • Rising Adoption of Minimally Invasive Procedures
    • Expansion of Indications for TAVR Procedures
    • Integration of Imaging and Navigation Technologies
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Transcatheter Aortic Valve Replacement Procedures by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Transcatheter Aortic Valve Replacement Procedures by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Transcatheter Aortic Valve Replacement Procedures by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Other Procedures by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Other Procedures by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Other Procedures by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 7: World Transcatheter Aortic Valve Replacement Procedures Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Transfemoral Procedure by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Transfemoral Procedure by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Transfemoral Procedure by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Subclavian Procedure by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Subclavian Procedure by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Subclavian Procedure by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Transcatheter Aortic Valve Replacement Procedures Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 14: USA Recent Past, Current & Future Analysis for Transcatheter Aortic Valve Replacement Procedures by Procedure - Transfemoral Procedure, Subclavian Procedure and Other Procedures - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 15: USA Historic Review for Transcatheter Aortic Valve Replacement Procedures by Procedure - Transfemoral Procedure, Subclavian Procedure and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 16: USA 16-Year Perspective for Transcatheter Aortic Valve Replacement Procedures by Procedure - Percentage Breakdown of Value Sales for Transfemoral Procedure, Subclavian Procedure and Other Procedures for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 17: Canada Recent Past, Current & Future Analysis for Transcatheter Aortic Valve Replacement Procedures by Procedure - Transfemoral Procedure, Subclavian Procedure and Other Procedures - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 18: Canada Historic Review for Transcatheter Aortic Valve Replacement Procedures by Procedure - Transfemoral Procedure, Subclavian Procedure and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: Canada 16-Year Perspective for Transcatheter Aortic Valve Replacement Procedures by Procedure - Percentage Breakdown of Value Sales for Transfemoral Procedure, Subclavian Procedure and Other Procedures for the Years 2014, 2024 & 2030
  • JAPAN
    • Transcatheter Aortic Valve Replacement Procedures Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 20: Japan Recent Past, Current & Future Analysis for Transcatheter Aortic Valve Replacement Procedures by Procedure - Transfemoral Procedure, Subclavian Procedure and Other Procedures - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 21: Japan Historic Review for Transcatheter Aortic Valve Replacement Procedures by Procedure - Transfemoral Procedure, Subclavian Procedure and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: Japan 16-Year Perspective for Transcatheter Aortic Valve Replacement Procedures by Procedure - Percentage Breakdown of Value Sales for Transfemoral Procedure, Subclavian Procedure and Other Procedures for the Years 2014, 2024 & 2030
  • CHINA
    • Transcatheter Aortic Valve Replacement Procedures Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 23: China Recent Past, Current & Future Analysis for Transcatheter Aortic Valve Replacement Procedures by Procedure - Transfemoral Procedure, Subclavian Procedure and Other Procedures - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 24: China Historic Review for Transcatheter Aortic Valve Replacement Procedures by Procedure - Transfemoral Procedure, Subclavian Procedure and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: China 16-Year Perspective for Transcatheter Aortic Valve Replacement Procedures by Procedure - Percentage Breakdown of Value Sales for Transfemoral Procedure, Subclavian Procedure and Other Procedures for the Years 2014, 2024 & 2030
  • EUROPE
    • Transcatheter Aortic Valve Replacement Procedures Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 26: Europe Recent Past, Current & Future Analysis for Transcatheter Aortic Valve Replacement Procedures by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 27: Europe Historic Review for Transcatheter Aortic Valve Replacement Procedures by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: Europe 16-Year Perspective for Transcatheter Aortic Valve Replacement Procedures by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 29: Europe Recent Past, Current & Future Analysis for Transcatheter Aortic Valve Replacement Procedures by Procedure - Transfemoral Procedure, Subclavian Procedure and Other Procedures - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 30: Europe Historic Review for Transcatheter Aortic Valve Replacement Procedures by Procedure - Transfemoral Procedure, Subclavian Procedure and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: Europe 16-Year Perspective for Transcatheter Aortic Valve Replacement Procedures by Procedure - Percentage Breakdown of Value Sales for Transfemoral Procedure, Subclavian Procedure and Other Procedures for the Years 2014, 2024 & 2030
  • FRANCE
    • Transcatheter Aortic Valve Replacement Procedures Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 32: France Recent Past, Current & Future Analysis for Transcatheter Aortic Valve Replacement Procedures by Procedure - Transfemoral Procedure, Subclavian Procedure and Other Procedures - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: France Historic Review for Transcatheter Aortic Valve Replacement Procedures by Procedure - Transfemoral Procedure, Subclavian Procedure and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: France 16-Year Perspective for Transcatheter Aortic Valve Replacement Procedures by Procedure - Percentage Breakdown of Value Sales for Transfemoral Procedure, Subclavian Procedure and Other Procedures for the Years 2014, 2024 & 2030
  • GERMANY
    • Transcatheter Aortic Valve Replacement Procedures Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 35: Germany Recent Past, Current & Future Analysis for Transcatheter Aortic Valve Replacement Procedures by Procedure - Transfemoral Procedure, Subclavian Procedure and Other Procedures - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Germany Historic Review for Transcatheter Aortic Valve Replacement Procedures by Procedure - Transfemoral Procedure, Subclavian Procedure and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: Germany 16-Year Perspective for Transcatheter Aortic Valve Replacement Procedures by Procedure - Percentage Breakdown of Value Sales for Transfemoral Procedure, Subclavian Procedure and Other Procedures for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 38: Italy Recent Past, Current & Future Analysis for Transcatheter Aortic Valve Replacement Procedures by Procedure - Transfemoral Procedure, Subclavian Procedure and Other Procedures - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Italy Historic Review for Transcatheter Aortic Valve Replacement Procedures by Procedure - Transfemoral Procedure, Subclavian Procedure and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: Italy 16-Year Perspective for Transcatheter Aortic Valve Replacement Procedures by Procedure - Percentage Breakdown of Value Sales for Transfemoral Procedure, Subclavian Procedure and Other Procedures for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Transcatheter Aortic Valve Replacement Procedures Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 41: UK Recent Past, Current & Future Analysis for Transcatheter Aortic Valve Replacement Procedures by Procedure - Transfemoral Procedure, Subclavian Procedure and Other Procedures - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: UK Historic Review for Transcatheter Aortic Valve Replacement Procedures by Procedure - Transfemoral Procedure, Subclavian Procedure and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: UK 16-Year Perspective for Transcatheter Aortic Valve Replacement Procedures by Procedure - Percentage Breakdown of Value Sales for Transfemoral Procedure, Subclavian Procedure and Other Procedures for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 44: Rest of Europe Recent Past, Current & Future Analysis for Transcatheter Aortic Valve Replacement Procedures by Procedure - Transfemoral Procedure, Subclavian Procedure and Other Procedures - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Rest of Europe Historic Review for Transcatheter Aortic Valve Replacement Procedures by Procedure - Transfemoral Procedure, Subclavian Procedure and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: Rest of Europe 16-Year Perspective for Transcatheter Aortic Valve Replacement Procedures by Procedure - Percentage Breakdown of Value Sales for Transfemoral Procedure, Subclavian Procedure and Other Procedures for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Transcatheter Aortic Valve Replacement Procedures Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 47: Asia-Pacific Recent Past, Current & Future Analysis for Transcatheter Aortic Valve Replacement Procedures by Procedure - Transfemoral Procedure, Subclavian Procedure and Other Procedures - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Asia-Pacific Historic Review for Transcatheter Aortic Valve Replacement Procedures by Procedure - Transfemoral Procedure, Subclavian Procedure and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Asia-Pacific 16-Year Perspective for Transcatheter Aortic Valve Replacement Procedures by Procedure - Percentage Breakdown of Value Sales for Transfemoral Procedure, Subclavian Procedure and Other Procedures for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • TABLE 50: Rest of World Recent Past, Current & Future Analysis for Transcatheter Aortic Valve Replacement Procedures by Procedure - Transfemoral Procedure, Subclavian Procedure and Other Procedures - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Rest of World Historic Review for Transcatheter Aortic Valve Replacement Procedures by Procedure - Transfemoral Procedure, Subclavian Procedure and Other Procedures Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Rest of World 16-Year Perspective for Transcatheter Aortic Valve Replacement Procedures by Procedure - Percentage Breakdown of Value Sales for Transfemoral Procedure, Subclavian Procedure and Other Procedures for the Years 2014, 2024 & 2030

IV. COMPETITION